MATRISYS BIOSCIENCE
MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients.
MATRISYS BIOSCIENCE
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.matrisysbio.com
Total Employee:
1+
Status:
Active
Contact:
(858)456-3919
Total Funding:
4.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome WordPress 6.0 Typekit
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Current Advisors List
Board_member
2015-03-01
Board_member
2019-03-01
Board_member
2020-04-01
Current Employees Featured
Magda Marquet Director Board Of Directors @ MatriSys Bioscience
Director Board Of Directors
2018-10-01
Richard Gallo Co-Founder and Head @ MatriSys Bioscience
Co-Founder and Head
Philippe P. Calais President and CEO @ MatriSys Bioscience
President and CEO
2020-10-01
Founder
Investors List
Primer Capital
Primer Capital investment in Venture Round - MatriSys Bioscience
Tech Coast Angels
Tech Coast Angels investment in Venture Round - MatriSys Bioscience
Tech Coast Angels
Tech Coast Angels investment in Venture Round - MatriSys Bioscience
Primer Capital
Primer Capital investment in Seed Round - MatriSys Bioscience
Tech Coast Angels
Tech Coast Angels investment in Venture Round - MatriSys Bioscience
Official Site Inspections
http://www.matrisysbio.com
- Host name: dp-dfa6319473.dreamhostps.com
- IP address: 107.180.246.67
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "MatriSys Bioscience"
MatriSys Bio - HARNESSING BENEFICIAL BACTERIA
Our groundbreaking technology platform identifies beneficial bacteria derived from healthy human skin to potentially treat the millions of children and adults suffering from difficult to treat chronic …See details»
About Us - MatriSys Bio
MatriSys Bioscience is leading the discovery and clinical development of a novel class of biopharmaceuticals to transform the treatment of chronic skin diseases. Our groundbreaking …See details»
MatriSys Bioscience - Crunchbase Company Profile
MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live …See details»
MatriSys Bioscience, Inc. | LinkedIn
MatriSys Bioscience, Inc. Biotechnology Research La Jolla, California 553 followers Harnessing beneficial bacteria to treat chronic inflammatory skin conditions.See details»
MATRISYS BIO SCIENCE INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for MATRISYS BIO SCIENCE INC of La Jolla, CA. Get the latest business insights from Dun & Bradstreet.See details»
MatriSys Bioscience 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for MatriSys Bioscience. Use the PitchBook Platform to explore the full profile.See details»
MatriSys Bioscience - VentureRadar
"MatriSys Bioscience (MatriSys Bio) is a clinical stage Specialty Biopharmaceutical Company focused on developing and commercializing rational microbiome therapies for the top five …See details»
MatriSys Bioscience, Inc. (MatriSys Bioscience, Inc.) - 药物管线_专 …
MatriSys and its advisors Evolution Life Science Partners to host 1-on-1 meetings during the JP Morgan conference January 8-12 LA JOLLA, Calif., Jan. 4, 2023 /PRNewswire/ --Matrisys …See details»
MatriSys Bioscience, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore MatriSys Bioscience, Inc. with its drug pipeline, therapeutic area, technology platform, 7 news, Disease Domain:Immune System Diseases, Neoplasms, Technology ...See details»
MatriSys Bioscience - Craft
MatriSys Bioscience has 5 employees at their 1 location and $1.5 m in total funding,. See insights on MatriSys Bioscience including office locations, competitors, revenue, financials, executives, …See details»
About Us – [webform] - MatriSys Bio
About Us MatriSys Bioscience is leading the discovery and clinical development of a novel class of biopharmaceuticals to transform the treatment of chronic skin diseases. Our groundbreaking …See details»
Overview, News & Similar companies - ZoomInfo.com
Jul 29, 2021 View MatriSys Bioscience (www.cennabiosciences.com) location in California, United States , revenue, industry and description. Find related and similar companies as well …See details»
MatriSys Bioscience - VentureRadar
MatriSys Bioscience (MatriSys Bio) is a clinical stage Specialty Biopharmaceutical Company focused on developing and commercializing rational microbiome therapies for the top five …See details»
MatriSys Bioscience Announces Corporate and Strategic Update
Jan 4, 2023 MatriSys Bioscience's groundbreaking technology platform identifies beneficial bacteria selected from human skin and develops these into treatments for chronic …See details»
MatriSys Bioscience announces corporate and strategic update
Jan 3, 2023 MatriSys Bioscience announces corporate and strategic update MatriSys and its advisors Evolution Life Science Partners to host 1-on-1 meetings during the JP Morgan …See details»
MatriSys Bioscience names Dr. Phillipe Calais as its New Chief ...
Dec 1, 2020 Prior to joining MatriSys Bio, Dr. Calais served as interim CEO and board member at CohBar Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing …See details»
Simplification for success: Rewiring the biopharma operating model
Mar 21, 2025 Less than a third of the 50 leaders we surveyed believe their organization currently possesses the talent and capabilities required to support future product portfolios, including …See details»
MatriSys Bioscience Announces Corporate and Strategic Update
Jan 4, 2023 MatriSys and its advisors Evolution Life Science Partners to host 1-on-1 meetings during the JP Morgan conference January 8-12 LA JOLLA, Calif., Jan. 4, 2023 /PRNewswire/ …See details»
MatriSys Bioscience Announces Corporate and Strategic Update
Jan 4, 2023 MatriSys Bioscience’s groundbreaking technology platform identifies beneficial bacteria selected from human skin and develops these into treatments for chronic …See details»
Culture Biosciences unveils Stratyx™ 250, the first cloud
2 days ago Stratyx™ 250 is an innovative new bioreactor system from Culture Biosciences that accelerates bioprocess development, reduces costs and provides real-time remote control and …See details»